Amarin lost their patent dispute loosing any advantage they might have had regarding the patent for their Vascepa drug,.
- No patent means anyopne can make and distribute the drug.
- Prices will drop 80%-90%
- No point hanging on to this investment. I have better things to do with the funds.
- Selling @ $4.04 afte buying on March 13th @ $12.57 - Taking a 67% Loss.